Found 905 matching trials
Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Non-Anaplastic Non-Medullary Thyroid Cancer PHASE2 The purpose of this Phase 2 study is to find out what effect, good and/or b...
Show More Location
Memorial Sloan Kettering Basking Ridge
Learn More & Join Trial
In Vivo Involvement of the Cholinergic and Dopaminergic Systems in the Pathophysiology of Apathy. PHASE3 Apathy is a neurocognitive syndrome characterized by reduced goal-directed ...
Show More Location
Bordeaux University Hospital
Learn More & Join Trial
De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA PHASE2 This phase II trial examines the use of blood-based biomarkers is to help i...
Show More Location
Mayo Clinic in Arizona
Learn More & Join Trial
Transcriptional and Epigenetic Program of PCOS Women N/A The main goal is to reveal differences in global gene expression in two dif...
Show More Status
Active Not Recruiting
Location
AdventHealth Translational Research Institute
Learn More & Join Trial
Measurement of Brain Perfusion by a MR Perfusion Imaging Called eASL in Children's Cerebral Arteriopathies. N/A The MR sequence called MR-ASL is used to measure cerebral perfusion in chil...
Show More Location
Hôpital Necker-Enfants Malades
Learn More & Join Trial
Prostate Cancer Secondary Screening in Sapienza and Policlinico Umberto I NA Prostate Cancer (PCa) screening is still a controversial topic in the urolo...
Show More Location
Sapienza University of Rome
Learn More & Join Trial
Dasatinib and Quercetin With CAR-T Therapy for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma PHASE2 This phase II trial tests how well giving dasatinib and quercetin with cycl...
Show More Location
Mayo Clinic in Rochester
Learn More & Join Trial
Romidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive Iodine PHASE2 This phase II trial is studying how well romidepsin works in treating patie...
Show More Location
Memorial Sloan-Kettering Cancer Center at Suffolk
Learn More & Join Trial
Autologous CD8+ and CD4+ Transgenic T Cells Expressing High Affinity KRASG12V Mutation-Specific T Cell Receptors (FH-A11KRASG12V-TCR) in Treating Patients With Metastatic Solid Tumor Cancers With KRAS G12V Mutations PHASE1 This phase I trial studies the side effects and best dose of autologous CD8...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma PHASE1 This phase I trial studies the side effects and best dose of genetically mo...
Show More Status
Active Not Recruiting
Location
City of Hope Medical Center
Learn More & Join Trial